Concepedia

Author

Irene Nowotny

Sanofi (Germany)

Also Known As

I Nowotny, I. Nowotny, IRENE K. NOWOTNY, Irene Nowotny

16

Publications

421

Citations

8

H-Index

10

Concepts

All Affiliations

Sanofi (Germany)Profil Institute for Metabolic ResearchSanofi (France)
IN

About

Irene Nowotny is an author at Sanofi (Germany) specializing in drug resistance, antibiotics, and sepsis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

33

2

Medicine

1

1

33

3

Antibiotics

1

1

33

4

Antimicrobial Pharmacokinetics

1

1

33

5

Clinical Microbiology

1

1

33

Irene Nowotny

×

7

Publications

389

Citations

7

H-Index

YearCitations

Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist

Martin Bossart, Michael Wagner, Ralf Elvert,

Cell Metabolism

2021

160

Low within‐ and between‐day variability in exposure to new insulin glargine 300 U/ml

R. H. A. Becker, Irene Nowotny, Lenore Teichert,

Diabetes Obesity and Metabolism

2014

124

Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial

A. Geddes, Michael Thaler, S Schönwald,

Journal of Antimicrobial Chemotherapy

1999

33

Similar pharmacokinetics and pharmacodynamics of rapid‐acting insulin lispro products <scp>SAR342434</scp> and <scp>US</scp> ‐ and <scp>EU</scp> ‐approved Humalog in subjects with type 1 diabetes

Christoph Kapitza, Irene Nowotny, Anne Lehmann,

Diabetes Obesity and Metabolism

2016

28

Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes

Christoph Kapitza, Leszek Nosek, Wolfgang Schmider,

Diabetes Technology & Therapeutics

2019

18

Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump

James Thrasher, Howard K. Surks, Irene Nowotny,

Journal of Diabetes Science and Technology

2018

16

Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes

Harald Pohlmeier, Lori Berard, Claire Brulle-Wohlhueter,

Journal of Diabetes Science and Technology

2016

10

Page 1